Reema K Tawfiq - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Reema K Tawfiq

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Current Hematologic Malignancy Reports|March 27, 2024

Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström MacroglobulinemiaReema K Tawfiq, Jithma P Abeykoon, Prashant Kapoor

Faculty Reviews|December 19, 2022

Monoclonal gammopathy of undetermined significance: evaluation, risk assessment, management, and beyondJithma P Abeykoon, Reema K Tawfiq, Shaji Kumar, et al.

Blood Cancer Journal|November 13, 2023

Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort studyAllison M Bock, Jennifer J Gile, Melissa C Larson, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Current Hematologic Malignancy Reports|March 27, 2024

Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström MacroglobulinemiaReema K Tawfiq, Jithma P Abeykoon, Prashant Kapoor

Faculty Reviews|December 19, 2022

Monoclonal gammopathy of undetermined significance: evaluation, risk assessment, management, and beyondJithma P Abeykoon, Reema K Tawfiq, Shaji Kumar, et al.

Blood Cancer Journal|November 13, 2023

Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort studyAllison M Bock, Jennifer J Gile, Melissa C Larson, et al.

Pageof 1